Ligand · VO1
VO1 · 3-(benzyloxy)-N-(4-methyl-1,3-thiazol-2-yl)pyridin-2-amine
VO1, 3-(benzyloxy)-N-(4-methyl-1,3-thiazol-2-yl)pyridin-2-amine (C16 H15 N3 O S, 297.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it…
- Component
- VO1
- Formula
- C16 H15 N3 O S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
VO1 in 2 structures; the first of them:
- 4MLE · Human Glucokinase in Complex with Novel Amino Thiazole Activator · VO1 A502 · binds TYR61, VAL62, ARG63, SER64, PRO66, ILE159, MET210, ILE211 and 8 more
- 4MLE · Human glucokinase in complex with novel amino thiazole activator · VO1 A502 · binds TYR61, VAL62, ARG63, SER64, PRO66, ILE159, MET210, ILE211 and 8 more
Residues it binds most
TYR 2, VAL 2, ILE 2, MET 2, ARG 2, CYS 2, GLU 2, LEU 2, PRO 2, SER 2 (residue and the binding sites it lines).
Found with
- GLC · alpha-D-glucopyranose
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.